Pernix Commences Refinancing Transactions to Fortify Balance Sheet

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Pernix Commences Refinancing Transactions to Fortify Balance Sheet

Pernix Therapeutics (PTX) Reports Prelim. Q2 Revenue of $33M-$35M

July 20, 2017 4:57 PM EDT

Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX) today announced certain preliminary unaudited financial results for the second quarter ended June 30, 2017.

Second Quarter 2017 Preliminary Unaudited Financial Highlights:

Second quarter 2017 net revenues are expected to be between $33.0 million and $35.0 million, which would represent a decrease of between 5% and 10% versus second quarter 2016 net revenues of $36.7 million.Second quarter 2017 selling, general and administrative expense is expected to be between $18.0... More